
Through an association, the location will promote access to cannabis-based treatments in an unprecedented way in the municipality

Research from USP with an animal model reveals that cannabidiol (CBD) can simultaneously alleviate neuropathic pain and symptoms of depression, showing itself as a promising therapeutic alternative to traditional medications

Shipping cannabis products via the Post Office is still prohibited, but companies are finding specialized solutions to meet the growing demand of the medicinal market

Patients with ASD, fibromyalgia, and chronic pain will be able to access cannabidiol-based medications through the public network

Sustainability, industrial innovation, and regulatory support drive the accelerated growth of hemp as a strategic raw material

Compound present in cannabis demonstrates promising therapeutic effects in mucoadhesive strips, regulating appetite, metabolism, and insulin sensitivity

Emergency decree ignores Parliament and sparks immediate reaction

Letter was signed during an event in reference to World Autism Awareness Day, featuring Eduardo Suplicy and Paulo Teixeira

Ketamine as an ally in the treatment of resistant depression and suicidal thoughts

Proximity to major markets places Paraguay in a strategic position to lead cannabis production in South America

CFF will appeal the court decision that suspended Resolution No. 586/2013

The Ministry of Agriculture is finalizing a technical note related to the bill currently in the Senate

Combining health and flavor, mushroom-infused coffee attracts consumers seeking energy and well-being

Agreement aims to ensure high-quality and safe products for patients in need of plant-based treatments

After decades of discussions, the agency advances its agenda aiming to create a genetic bank of the plant in Brazil

Step-by-step guide for patients with specific conditions

New regulations and impacts on government research

Bloomberg speculates on the reasons leading the country to this process of recriminalization

Company releases report on the current legislation in the European continent regarding the regulation of cannabis uses

CBCM 2024 promises new perspectives on treatments and research